Beijing Kawin Technology Share-holding Co Ltd
SSE:688687

Watchlist Manager
Beijing Kawin Technology Share-holding Co Ltd Logo
Beijing Kawin Technology Share-holding Co Ltd
SSE:688687
Watchlist
Price: 27.49 CNY -2.97% Market Closed
Market Cap: 4.6B CNY
Have any thoughts about
Beijing Kawin Technology Share-holding Co Ltd?
Write Note

Relative Value

The Relative Value of one Beijing Kawin Technology Share-holding Co Ltd stock under the Base Case scenario is 45.09 CNY. Compared to the current market price of 27.49 CNY, Beijing Kawin Technology Share-holding Co Ltd is Undervalued by 39%.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

Relative Value
Base Case
45.09 CNY
Undervaluation 39%
Relative Value
Price
Worst Case
Base Case
Best Case

Valuation Multiples

vs History
27
vs Industry
75
Median 3Y
3
Median 5Y
2.7
Industry
8.1
Forward
2.8
vs History
36
vs Industry
5
Median 3Y
37.4
Median 5Y
32.6
Industry
23
Forward
32.9
vs History
17
vs Industry
8
Median 3Y
27.4
Median 5Y
25.8
Industry
23.4
vs History
27
vs Industry
5
Median 3Y
25.6
Median 5Y
-38.7
Industry
27.3
vs History
29
vs Industry
39
Median 3Y
2.4
Median 5Y
2.4
Industry
2.6
vs History
25
vs Industry
68
Median 3Y
2.2
Median 5Y
1.9
Industry
8.1
Forward
2.2
vs History
25
vs Industry
66
Median 3Y
2.6
Median 5Y
2.2
Industry
9.6
vs History
48
vs Industry
6
Median 3Y
23.7
Median 5Y
22.7
Industry
4.3
Forward
17.7
vs History
48
vs Industry
6
Median 3Y
23.7
Median 5Y
22.7
Industry
3.8
Forward
14.9
vs History
17
vs Industry
9
Median 3Y
19.4
Median 5Y
15.7
Industry
6
vs History
vs Industry
3
Median 3Y
-35.8
Median 5Y
-53.4
Industry
3.8
vs History
53
vs Industry
38
Median 3Y
3.8
Median 5Y
3.8
Industry
4.8

Multiples Across Competitors

Competitors Multiples
Beijing Kawin Technology Share-holding Co Ltd Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
CN
Beijing Kawin Technology Share-holding Co Ltd
SSE:688687
4.6B CNY 3.2 38.2 22.1 22.1
FR
Pharnext SCA
OTC:PNEXF
6T USD 37 563 478.2 -178 533.6 -216 796.7 -214 322.8
US
Abbvie Inc
NYSE:ABBV
300.2B USD 5.4 59 14.8 22.8
US
Amgen Inc
NASDAQ:AMGN
159.1B USD 4.9 37.4 17.5 33.2
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
126.6B USD 11.9 -263.9 26.7 28
US
Gilead Sciences Inc
NASDAQ:GILD
114.6B USD 4.1 910.1 10.1 10.1
US
Epizyme Inc
F:EPE
94.1B EUR 1 875.5 -478.6 -521.2 -507.3
AU
CSL Ltd
ASX:CSL
137.3B AUD 6 33.7 20.8 25.9
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
87.6B USD 6.3 18.8 17.3 19.2
US
Seagen Inc
F:SGT
39.3B EUR 18.1 -55.4 -59.5 -53.7
NL
argenx SE
XBRU:ARGX
34.1B EUR 18.5 -129.9 -104.5 -76.1
P/E Multiple
Earnings Growth
CN
Beijing Kawin Technology Share-holding Co Ltd
SSE:688687
Average P/E: 182.9
38.2
116%
FR
Pharnext SCA
OTC:PNEXF
Negative Multiple: -178 533.6 N/A
US
Abbvie Inc
NYSE:ABBV
59
412%
US
Amgen Inc
NASDAQ:AMGN
37.4
73%
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
Negative Multiple: -263.9
42%
US
Gilead Sciences Inc
NASDAQ:GILD
910.1
75%
US
E
Epizyme Inc
F:EPE
Negative Multiple: -478.6 N/A
AU
CSL Ltd
ASX:CSL
33.7
65%
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
18.8
43%
US
S
Seagen Inc
F:SGT
Negative Multiple: -55.4 N/A
NL
argenx SE
XBRU:ARGX
Negative Multiple: -129.9 N/A
EV/EBITDA Multiple
EBITDA Growth
CN
Beijing Kawin Technology Share-holding Co Ltd
SSE:688687
Average EV/EBITDA: 18.5
22.1
166%
FR
Pharnext SCA
OTC:PNEXF
Negative Multiple: -216 796.7 N/A
US
Abbvie Inc
NYSE:ABBV
14.8
28%
US
Amgen Inc
NASDAQ:AMGN
17.5
63%
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
26.7
38%
US
Gilead Sciences Inc
NASDAQ:GILD
10.1
12%
US
E
Epizyme Inc
F:EPE
Negative Multiple: -521.2 N/A
AU
CSL Ltd
ASX:CSL
20.8
42%
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
17.3
46%
US
S
Seagen Inc
F:SGT
Negative Multiple: -59.5 N/A
NL
argenx SE
XBRU:ARGX
Negative Multiple: -104.5 N/A
EV/EBIT Multiple
EBIT Growth
CN
Beijing Kawin Technology Share-holding Co Ltd
SSE:688687
Average EV/EBIT: 23
22.1
N/A
FR
Pharnext SCA
OTC:PNEXF
Negative Multiple: -214 322.8 N/A
US
Abbvie Inc
NYSE:ABBV
22.8
88%
US
Amgen Inc
NASDAQ:AMGN
33.2
93%
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
28
44%
US
Gilead Sciences Inc
NASDAQ:GILD
10.1
29%
US
E
Epizyme Inc
F:EPE
Negative Multiple: -507.3 N/A
AU
CSL Ltd
ASX:CSL
25.9
55%
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
19.2
54%
US
S
Seagen Inc
F:SGT
Negative Multiple: -53.7 N/A
NL
argenx SE
XBRU:ARGX
Negative Multiple: -76.1 N/A

See Also

Discover More
Back to Top